Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc. (ISRG)
Compare

Intuitive Surgical, Inc. (ISRG) Net Income CAGR:20.33%(TTM)

Stocks/ISRG Stock/Performance/net income cagr
Compare

The net income cagr for Intuitive Surgical, Inc. (ISRG) is +20.33% over the latest trailing 12-month period. Net income CAGR uses precomputed financial statement history.

The net income CAGR for Intuitive Surgical, Inc. (ISRG) stock is 20.33% over the past 12 months. The 3 year CAGR is 31.43% and the 5 year CAGR is 20.49%. Net income CAGR shows how Intuitive Surgical, Inc.'s bottom-line profitability has grown. This reflects the company's ability to convert revenue into profits after all expenses.

ISRG Net Income CAGR Chart

Intuitive Surgical, Inc. (ISRG)

ISRG Net Income CAGR History

YearStart Net IncomeEnd Net IncomeChange% ChangeCAGR
2025$2.32B$2.86B+$533.40M+22.97%+22.97%
2024$1.80B$2.32B+$524.60M+29.18%+29.18%
2023$1.32B$1.80B+$475.70M+35.98%+35.98%
2022$1.70B$1.32B$-382.30M-22.43%-22.43%
2021$1.06B$1.70B+$644.00M+60.72%+60.72%
2020$1.38B$1.06B$-318.70M-23.11%-23.11%
2019$1.13B$1.38B+$251.40M+22.29%+22.29%
2018$660.00M$1.13B+$467.90M+70.89%+70.89%
2017$735.90M$660.00M$-75.90M-10.31%-10.31%
2016$588.80M$735.90M+$147.10M+24.98%+24.98%
2015$418.80M$588.80M+$170.00M+40.59%+40.59%
2014$671.00M$418.80M$-252.20M-37.59%-37.59%
2013$656.60M$671.00M+$14.40M+2.19%+2.19%
2012$495.10M$656.60M+$161.50M+32.62%+32.62%
2011$381.80M$495.10M+$113.30M+29.68%+29.68%
2010$232.61M$381.80M+$149.19M+64.14%+64.14%
2009$204.31M$232.61M+$28.29M+13.85%+13.85%
2008$144.54M$204.31M+$59.78M+41.36%+41.36%
2007$72.04M$144.54M+$72.49M+100.62%+100.62%
2006$94.13M$72.04M$-22.09M-23.47%-23.47%
2005$23.48M$94.13M+$70.66M+300.95%+300.95%
2004$-9.62M$23.48M+$33.10M+0.00%N/A
2003$-18.42M$-9.62M+$8.80M+0.00%N/A
2002$-16.70M$-18.42M$-1.72M+0.00%N/A
2001$-18.52M$-16.70M+$1.82M+0.00%N/A
2000$-18.41M$-18.52M$-108.00K+0.00%N/A
1999$-29.44M$-18.41M+$11.03M+0.00%N/A

Quarterly Net Income — QoQ & YoY

QuarterValueQoQYoY
Q1 2026$821.50M+3.4%+17.6%
Q4 2025$794.80M+12.8%+15.9%
Q3 2025$704.40M+7.0%+24.7%
Q2 2025$658.40M-5.7%+25.0%
Q1 2025$698.40M+1.9%+28.2%
Q4 2024$685.70M+21.3%+13.1%
Q3 2024$565.10M+7.2%+35.9%
Q2 2024$526.90M-3.3%+25.2%
Q1 2024$544.90M-10.1%+53.4%
Q4 2023$606.20M+45.8%+86.6%
Q3 2023$415.70M-1.2%+28.3%
Q2 2023$420.80M+18.4%+36.7%
Q1 2023$355.30M+9.4%-2.8%
Q4 2022$324.90M+0.3%-14.6%
Q3 2022$324.00M+5.3%-14.8%
Q2 2022$307.80M-15.8%-40.5%

QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sunnyvale, CA
15,638 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
David J. Rosa